📊 Midday Market Take
| S&P 500 | ▲ | +0.77% |
| Nasdaq | ▲ | +1.41% |
| Dow Jones | ▲ | +0.34% |
Hey, happy Tuesday, and the market is making it worth your while today. The S&P 500 is up 0.77%, the Nasdaq is leading the charge at plus 1.41%, and even the Dow is along for the ride at plus 0.34%.
Tech is the story driving that Nasdaq pop, and if you have exposure there, today is a good reminder not to trim too early. Growth-oriented investors might use this momentum as a signal to review any underweight positions in large-cap tech before the afternoon close.
ABIVAX Société Anonyme
|
Price
$134.91
|
Today
+40.31%
|
30 Day
+18.81%
|
90 Day
+3.50%
|
1 Year
+1663.56%
|
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
3 Reasons to Watch ABVX
- Obefazimod Just Delivered Big For Tough Cases. Abivax dropped Phase 3 maintenance data showing obefazimod produced meaningful clinical benefit in refractory ulcerative colitis patients, the hardest-to-treat group where most drugs fall flat. That kind of result in relapsed and non-responding patients is exactly what separates a crowded IBD pipeline from one worth serious attention.
- A 40% Single-Session Pop Demands Follow-Through Watching. Shares closed up over 40% in the most recent session, a move that rarely settles cleanly when markets reopen and volume floods back in. Whether that gap holds or gets tested early will tell you a lot about how institutional money is sizing up the data.
- One Year, One Thousand Six Hundred Sixty-Three Percent. ABVX has returned over 1,600% in the past year, which means the stock has a habit of making believers out of skeptics when the clinical pipeline delivers. With fresh Phase 3 safety and efficacy data now in hand, the question isn't whether this name has momentum, it's whether the next leg has a real scientific floor under it, and today's results suggest it just might.
After a recent visit to Tesla’s private factory in Fremont, California… The legendary angel investor who backed Uber and Robinhood early tweeted: "Nobody will remember that Tesla ever made a car. They will only remember [Elon’s new technology]… It is going to be the most transformative technology product ever made in the history of humanity.”
Click here to see what he foundTop Market Headlines
These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read The Full StoryHe Called Nvidia Before It Soared 5,000% (Ad)
He recommended Tesla before 3,500%, and AMD before 8,500%. Luke Lango has a track record few analysts alive can match. Now he's making his biggest call yet — ahead of the OpenAI and Anthropic IPOs.
Get the ticker here free.
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the AlertsThis CIO Says the AI Bubble Pops the Moment Good News Stops Moving Stocks
David Bahnsen, Chief Investment Officer at The Bahnsen Group, appeared on CNBC's Squawk Box this morning with a specific warning.
Read The Full StoryIs Apple's Latest Plunge the Canary in the Coal Mine for Tech Stocks?
Shares of Apple Inc. NASDAQ: AAPL have been trading around $280 recently, having given up all the gains they logged since the first week of May....
Read The Full StoryAI Just Signed the Dollar's Death Warrant (Ad)
AI isn't just writing emails and creating videos. It's being wired into the financial system itself… moving faster than anyone in the world can control. And every breakthrough pushes us closer to one thing: A fully digital, government-issued dollar. A CBDC. Once that switch flips, the rules change overnight. There is only one asset that will stand the test of time after some unhinged AI wipes the slate clean.
Click to see more and claim your free guide ->European stocks are poised to outdo their American peers. These catalysts explain why.
JPMorgan raises its year-end target for European stocks again.
Read The Full StoryElon's $480 Trillion Currency Masterplan (Ad)
He's waited 27 years for this moment. Elon Musk just launched his biggest disruption ever, which could totally reset how millions of people access their money and even pay tax.
Here's exactly what to buy to profit.
I believe Elon is about to make his latest invention available to the public. When he does, sales could go through the roof. And the stock price of one of his critical partners could soar. I expect Elon to make this announcement any day now. By the end of the month at the latest. But you never know with Elon… He could post it on X tomorrow. So, there's very little time to act.
Click here to find out the name of Elon's critical partner… The company he can't live without.📰 Further Reading
How is Nancy Pelosi worth $413 million on a $174,000 salary? For decades, the revolving door between Washington and Wall Street kept regular folks like you locked out. Thanks to a brand-new law… (One Jeff Brown was consulted by Congressional offices on…) The "Pelosi Paradox" is coming to a swift end...
Click here to discover how you could profit from this landmark moment.
Most investors are still talking about the IPO. Larry Benedict isn't. He says the SpaceX IPO was never the big opportunity. It was the trigger. And now that it's done, the "Final Phase of Elon's Master Plan" has begun — meaning billions of dollars could be forced into ONE specific ticker at any time...
Click here to find out what comes after the IPO — and get the ticker before it moves.
Trump’s GENIUS Act has given crypto its first official federal framework. While attention stays on Bitcoin, one overlooked coin could benefit the most—backed by skyrocketing volume, early fund activity, and pro-crypto policy momentum.
See the #1 Coin Riding Trump’s Crypto Revolution